Details van artikel 639 van 2466 gevonden artikelen
P2-377: A phase 2, double-blind, placebo-controlled study to evaluate the safety, tolerability, and effect on cognitive function of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment
Titel:
P2-377: A phase 2, double-blind, placebo-controlled study to evaluate the safety, tolerability, and effect on cognitive function of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment
Auteur:
Schmechel, Donald E. Gerard, Gary Vatakis, Nick G. Harper, Linda Ross, Joel S. Bari, Mohammed Walling, David Stedman, Mary Winston, Jaron L. Morimoto, Bruce Keith, Julian R.
Verschenen in:
Alzheimer's & dementia
Paginering:
Jaargang 4 (2008) nr. 4S pagina's 1 p.
Jaar:
2008
Inhoud:
Uitgever:
The Alzheimer's Association
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 639 van 2466 gevonden artikelen